Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Study of Resolute Coronary Stent System in Treating Diabetic Coronary Lesions

Trial Profile

Study of Resolute Coronary Stent System in Treating Diabetic Coronary Lesions

Completed
Phase of Trial: Phase IV

Latest Information Update: 20 Nov 2015

At a glance

  • Drugs Zotarolimus (Primary)
  • Indications Coronary artery disease; Coronary artery restenosis
  • Focus Therapeutic Use
  • Acronyms RESOLUTE-DM
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 16 Nov 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 22 Nov 2013 Planned end date changed from 1 Jun 2015 to 1 Jun 2016 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top